193 related articles for article (PubMed ID: 30988421)
1. Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study.
Hope-Stone L; Brown SL; Heimann H; Damato B
Eye (Lond); 2019 Sep; 33(9):1478-1484. PubMed ID: 30988421
[TBL] [Abstract][Full Text] [Related]
2. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
3. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S; ;
Eye (Lond); 2004 Mar; 18(3):283-9. PubMed ID: 15004578
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported Outcomes and Quality of Life After Treatment of Choroidal Melanoma: A Comparison of Enucleation Versus Radiotherapy in 1596 Patients.
Damato B; Hope-Stone L; Cooper B; Brown SL; Salmon P; Heimann H; Dunn LB
Am J Ophthalmol; 2018 Sep; 193():230-251. PubMed ID: 29555484
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
7. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
van Beek JGM; Buitendijk GHS; Timman R; Muller K; Luyten GPM; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2018 Dec; 96(8):841-848. PubMed ID: 30284368
[TBL] [Abstract][Full Text] [Related]
8. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
9. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM;
Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893
[TBL] [Abstract][Full Text] [Related]
10. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
[TBL] [Abstract][Full Text] [Related]
11. Results of proton radiotherapy for uveal melanomas.
Egger E; Zografos L; Munkel G; Böhringer T; Bercher L; Chamot L
Front Radiat Ther Oncol; 1997; 30():111-22. PubMed ID: 9205891
[No Abstract] [Full Text] [Related]
12. [Proton beam radiotherapy of uveal melanoma--preliminary results].
Romanowska-Dixon B; Pogrzebielski A; Bogdali A; Markiewicz A; Swakoń J; Olko P; Jezabek M; Sas-Korczyńska B; Pluta E
Klin Oczna; 2012; 114(3):173-9. PubMed ID: 23373396
[TBL] [Abstract][Full Text] [Related]
13. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
15. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant proton beam irradiation followed by transscleral resection of uveal melanoma in 106 cases.
Willerding GD; Cordini D; Moser L; Krause L; Foerster MH; Bechrakis NE
Br J Ophthalmol; 2016 Apr; 100(4):463-7. PubMed ID: 26224096
[TBL] [Abstract][Full Text] [Related]
17. Auditing outcomes after treatment of Scottish patients with uveal melanoma in Liverpool.
Wright PK; Damato BE
J R Coll Surg Edinb; 1999 Aug; 44(4):260-4. PubMed ID: 10453150
[TBL] [Abstract][Full Text] [Related]
18. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
[TBL] [Abstract][Full Text] [Related]
19. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation.
Marucci L; Ancukiewicz M; Lane AM; Collier JM; Gragoudas ES; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):842-6. PubMed ID: 20472356
[TBL] [Abstract][Full Text] [Related]
20. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]